Olmesartan Doc Generici (Olmesartan Medoxomil)

Olmesartan medoxil, the active ingredient in Olmesartan Doc Generici, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It treats hypertension and may be prescribed for adults requiring blood pressure control.

GNH USA supplies Olmesartan Doc Generici as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan medoxil is an antihypertensive agent that acts on the renin‑angiotensin system to lower blood pressure. - Essential hypertension: reduces systolic and diastolic pressure to target levels. - Diastolic hypertension: provides better control of diastolic readings. - Hypertension with cardiovascular risk: helps lower risk of stroke and myocardial infarction.

Adverse reactions reported with olmesartan medoxil vary in frequency and severity.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue - Nasal congestion - Diarrhoea - Upper respiratory tract infection

Serious or Rare Side Effects: - Angio‑edema affecting face, lips or tongue - Severe hypotension - Acute kidney injury - Hyperkalemia - Liver function test abnormalities - Bullous pemphigoid skin disorder

When prescribing olmesartan medoxil, clinicians should consider several safety aspects. - Renal impairment: adjust dose or monitor renal function regularly. - Hyperkalemia risk: check serum potassium before and during therapy. - Pregnancy: avoid use, especially in the second and third trimesters. - Concomitant diuretics: monitor blood pressure and electrolytes closely. - Elderly patients: start with a low dose and titrate cautiously. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Olmesartan medoxil may interact with several medicines that influence blood pressure or potassium balance.

Major Interactions (Avoid): - Aliskiren combined with dual RAS blockade (any R ‑  R  ​  ​  ​  )  

Moderate ": -  ");

Moderate ": ");

""" """ """ ""